Halozyme Therapeutics, Inc. (HALO)

70.36 -0.28 (-0.40%) USD  |  NASDAQ  |  Feb 24, 16:00
70.29 -0.07 (-0.10%) After-Hours: 20:00
More

Halozyme Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Johnson & Johnson Upgrade
Merck & Co., Inc. Upgrade
Skye Bioscience, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Stryker Corp. Upgrade